1. Home
  2. SMCI vs BBIO Comparison

SMCI vs BBIO Comparison

Compare SMCI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super Micro Computer Inc.

SMCI

Super Micro Computer Inc.

HOLD

Current Price

$39.97

Market Cap

16.0B

Sector

Technology

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$72.44

Market Cap

15.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMCI
BBIO
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0B
15.9B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
SMCI
BBIO
Price
$39.97
$72.44
Analyst Decision
Hold
Strong Buy
Analyst Count
18
25
Target Price
$34.69
$86.33
AVG Volume (30 Days)
47.1M
1.8M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
94.05
N/A
EPS
3.26
N/A
Revenue
$2,484,929,000.00
$502,076,000.00
Revenue This Year
$92.37
$89.45
Revenue Next Year
$21.47
$73.78
P/E Ratio
$11.93
N/A
Revenue Growth
11.68
126.26
52 Week Low
$19.48
$48.78
52 Week High
$58.78
$93.42

Technical Indicators

Market Signals
Indicator
SMCI
BBIO
Relative Strength Index (RSI) 55.59 30.63
Support Level $28.84 $70.65
Resistance Level $39.47 $79.57
Average True Range (ATR) 1.90 2.20
MACD -0.12 -0.66
Stochastic Oscillator 51.61 3.08

Price Performance

Historical Comparison
SMCI
BBIO

About SMCI Super Micro Computer Inc.

Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, high-performance computing, and the Internet of Things embedded markets. Its solutions include servers, storage systems, modular blade servers, workstations, full-rack scale solutions, networking devices, server sub-systems, and server management. These turn-key solutions are designed, developed, validated, and installed for AI datacenters. The company has one operating segment that develops and provides high-performance server solutions based upon a, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: